dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
Published 1 month ago • 60 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:20
dr tolaney on the potential role for biomarkers in early-stage her2 breast cancer
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer
-
1:53
dr. tolaney on navigating adjuvant therapy in early-stage her2 breast cancer
-
2:06
dr. tolaney on the apt and atempt trials in stage i her2 breast cancer
-
2:00
dr sara m. tolaney: challenges with treating, role of clinical trials in her2-positive breast cancer
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
1:39
dr tolaney on standard frontline treatment approaches in her2 breast cancer
-
4:36
phase iii clinical trials in her2-positive breast cancer
-
6:46
case 1: clinical trials in early-stage her2 breast cancer
-
1:38
dr. tolaney on cns recurrence in her2 breast cancer
-
8:40
clinical trials in breast cancer
-
2:12
using clinical trials in treatment: dr. sara tolaney | dana-farber cancer institute
-
1:39
dr. tolaney on sequencing strategies in metastatic her2 breast cancer
-
1:40
dr. han on the aphinity trial in her2 early-stage breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
2:46
sara tolaney, esmo 2022: clinical trial highlights in breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer